Cas:5591-33-3 3-[[10-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-10-oxodecanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid manufacturer & supplier

Chemical Name:3-[[10-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-10-oxodecanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid

CAS.NO:5591-33-3

Synonyms:Acidum josefamicum;Isophthalamic acid,5,5′-(octamethylenebis(carbonylimino))bis(N-methyl-2,4,6-triiodo;Iosefamic acid;MP 271;5,5′-(Octamethylenebis(carbonylimino))bis(N-methyl-2,4,6-triiodoisophthalamic acid);Acido iosefamico [INN-Spanish];Acide iosefamique [INN-French];Acidum iosefamicum [INN-Latin]

Molecular Formula:C₂₈H₂₈I₆N₄O₈

Molecular Weight:1309.97000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:891.6ºC at 760 mmHg

Density:2.365g/cm3

Index of Refraction:1.748

PSA:191.00000

Exact Mass:1309.62000

LogP:8.05560

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Acidum josefamicum chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acidum iosefamicum [INN-Latin] physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,5′-(Octamethylenebis(carbonylimino))bis(N-methyl-2,4,6-triiodoisophthalamic acid) Use and application,Acido iosefamico [INN-Spanish] technical grade,usp/ep/jp grade.

Related News: Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 3-[[10-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-10-oxodecanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 3-[[10-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-10-oxodecanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid supplier Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 3-[[10-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-10-oxodecanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid vendor At present, there are more than 8,000 domestic API manufacturers, but they mainly produce bulk APIs with low technical content. 3-[[10-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-10-oxodecanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid factory Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology.